MET as a drug target.
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Ravi
R
Salgia
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D019859:Proto-Oncogene Proteins c-met